RETA

Reata Pharmaceuticals, Inc. Class A Common Stock

Delisted

RETA was delisted on the 25th of September, 2023.

89 hedge funds and large institutions have $317M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
89
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$258K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$14.7M
2 +$8.71M
3 +$5.66M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.24M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.72M

Top Sellers

1 -$18.4M
2 -$6.22M
3 -$5.34M
4
AIC
AWM Investment Company
New York
-$3.16M
5
UOC
UBS O'Connor
Illinois
-$2.59M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$82.5M
2
$34.1M
3
$18.7M
4
$17.3M
5
$15.9M
6
$14.7M
7
$13M
8
$11M
9
$7.52M
10
$7.08M
11
$7.08M
12
$6.37M
13
$6.35M
14
$5.82M
15
$5.66M
16
$5.21M
17
$5.04M
18
$4.9M
19
$3.63M
20
$3.23M
21
$2.6M
22
$2.25M
23
$2.24M
24
$2.06M
25
$1.98M